RG
Rahul Gawande Sudhakar
About Rahul Gawande Sudhakar
Data last updated:
Rahul Gawande Sudhakar is a Director at Orbicular Pharmaceutical Technologies Private Limited (since 2019), Director at Invitron Advanced Analytics Private Limited (since 2022) and Director at Revitos Specialities Private Limited (since 2020). The companies operate in Pharma and FMCG. The 2 current companies with reported revenue have a combined latest revenue of ₹315 Cr; the largest is Orbicular Pharmaceutical Technologies Private Limited at ₹272 Cr (FY 2025). Earlier, Rahul Gawande Sudhakar was a Director at Aleor Dermaceuticals Limited (2016–2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Jul 2019 | 2008 | ₹272 Cr (FY 2025) | Active | |
| Director | 11 Oct 2022 | 2013 | ₹43.23 Cr (FY 2025) | Active | |
| Director | 01 Oct 2020 | 2017 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 18 Jul 2016 | 2016 | ₹16.23 Cr (FY 2021) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rahul Gawande Sudhakar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Balaji Boggarapu | Orbicular Pharmaceutical Technologies Private Limited | Company Secretary | |
| Bhaveshkumar Vallabhbhai Patel | 07932528 | Orbicular Pharmaceutical Technologies Private Limited , Invitron Advanced Analytics Private Limited | Director |
| Hiren Dasharathbhai Patel | 03560495 | Orbicular Pharmaceutical Technologies Private Limited , Invitron Advanced Analytics Private Limited | Director |
| Meena Mohan | 02121102 | Orbicular Pharmaceutical Technologies Private Limited , Invitron Advanced Analytics Private Limited and 1 more | Director |
| Sivaraman Mohan Mailatur | 02573448 | Orbicular Pharmaceutical Technologies Private Limited , Invitron Advanced Analytics Private Limited | Managing Director |
| Visalakshi Chandramouli | 03594109 | Orbicular Pharmaceutical Technologies Private Limited | Nominee Director |
| Vinay Mohan | 07140441 | Revitos Specialities Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rahul Gawande Sudhakar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rahul Gawande Sudhakar
Rahul Gawande Sudhakar currently holds 3 directorships: Orbicular Pharmaceutical Technologies Private Limited (Director, since 01 Jul 2019, revenue ₹272 Cr (FY 2025)); Invitron Advanced Analytics Private Limited (Director, since 11 Oct 2022, revenue ₹43.23 Cr (FY 2025)); Revitos Specialities Private Limited (Director, since 01 Oct 2020).
Rahul Gawande Sudhakar was first appointed on 18 Jul 2016 as Director at Aleor Dermaceuticals Limited. The most recent appointment on record is 11 Oct 2022 at Invitron Advanced Analytics Private Limited.
The 2 current companies of Rahul Gawande Sudhakar that report revenue have a combined latest revenue of ₹315 Cr: Orbicular Pharmaceutical Technologies Private Limited ₹272 Cr (FY 2025); Invitron Advanced Analytics Private Limited ₹43.23 Cr (FY 2025).
Rahul Gawande Sudhakar held 1 earlier board appointment: Aleor Dermaceuticals Limited (Director, 18 Jul 2016 to 28 Mar 2022).
The current boards of Rahul Gawande Sudhakar's companies include Balaji Boggarapu (Orbicular Pharmaceutical Technologies Private Limited), Bhaveshkumar Vallabhbhai Patel (Orbicular Pharmaceutical Technologies Private Limited), Hiren Dasharathbhai Patel (Orbicular Pharmaceutical Technologies Private Limited), Meena Mohan (Orbicular Pharmaceutical Technologies Private Limited), Sivaraman Mohan Mailatur (Orbicular Pharmaceutical Technologies Private Limited), Visalakshi Chandramouli (Orbicular Pharmaceutical Technologies Private Limited), among others.